Pfizer and Valneva's Lyme disease vaccine shows 70% efficacy in clinical trial

Euronews3/23/2026

Summary

Pfizer and Valneva's Lyme disease vaccine has demonstrated 70% efficacy in clinical trials. The companies report that these promising results could lead to regulatory approval, despite facing setbacks due to fewer cases than expected.

Share:XRedditLinkedIn

Advertisement

Lindy Score Breakdown (V4.2)

3h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes

Score BreakdownRisk 70

Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity

Stories gain Lindy status through source reputation, network consensus, and time survival.

Breaking Similar stories

Anti-Lindy Similar stories